Philips · 1 day ago
Director of Upstream Product Management – Ultrasound (Cambridge, MA / Bothell, WA)
Philips is a health technology company focused on providing quality healthcare for everyone. The Director of Upstream Product Management for Ultrasound is responsible for shaping and managing the product roadmap and lifecycle, ensuring seamless integration of product strategies and cross-functional collaboration to meet business goals.
B2BConsumer ElectronicsElectronicsLightingWellness
Responsibilities
Help define product platforms that support growth, product evolution by bringing customer insights
Work across R&D, Services and Operations to develop integrated offerings that meet the needs of priority customer segments, tailored by market
Set value-based price corridors and guidance for products/solutions; Coordinate pricing across product lines to ensure profitable growth
Develop business cases for new products and services for consideration in the portfolio management process
Develop and maintain five-year strategic vision for product roadmap (for internal stakeholders and customers)
Qualification
Required
12+ years in Product Management, Product Marketing or related field
Experience in healthcare/med-tech solutions businesses is required
Ultrasound experience is a strong plus
Bachelor's degree
Superior business acumen
Entrepreneurial and global mindset
Demonstrable communication skills
Ability to lead global organization to develop market leading products/solutions
Experienced people manager who has led a global team
Must be able to successfully perform the following minimum Physical, Cognitive and Environmental job requirements with or without accommodation
Preferred
MBA is a plus
Benefits
Annual incentive bonus
Sales commission
Long-term incentives
Generous PTO
401k (up to 7% match)
HSA (with company contribution)
Stock purchase plan
Education reimbursement
Company
Philips
Philips is a technology company that operates in various fields, including healthcare, consumer electronics, lighting, and home appliances.
Funding
Current Stage
Public CompanyTotal Funding
$4.23BKey Investors
EXOR N.V.Bill & Melinda Gates FoundationInnovative Health Initiative
2025-03-19Post Ipo Equity
2024-05-23Post Ipo Debt· $756.82M
2023-11-07Grant· $44.6M
Recent News
2026-01-22
2026-01-22
Company data provided by crunchbase